[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69633739D1 - 293-zellen mit erhöhter anhaftung. - Google Patents

293-zellen mit erhöhter anhaftung.

Info

Publication number
DE69633739D1
DE69633739D1 DE69633739T DE69633739T DE69633739D1 DE 69633739 D1 DE69633739 D1 DE 69633739D1 DE 69633739 T DE69633739 T DE 69633739T DE 69633739 T DE69633739 T DE 69633739T DE 69633739 D1 DE69633739 D1 DE 69633739D1
Authority
DE
Germany
Prior art keywords
cells
increased adhesion
adhesion
increased
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69633739T
Other languages
English (en)
Other versions
DE69633739T2 (de
Inventor
George Lysko
Abd Elshourbagy
Ellen Brawner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
GlaxoSmithKline LLC
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline LLC, SmithKline Beecham Corp filed Critical GlaxoSmithKline LLC
Publication of DE69633739D1 publication Critical patent/DE69633739D1/de
Application granted granted Critical
Publication of DE69633739T2 publication Critical patent/DE69633739T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0684Cells of the urinary tract or kidneys
    • C12N5/0686Kidney cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50Cell markers; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00Use of cells in diagnostics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69633739T 1995-05-30 1996-05-30 293-zellen mit erhöhter anhaftung. Expired - Lifetime DE69633739T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US453117 1995-05-30
US08/453,117 US5683903A (en) 1995-05-30 1995-05-30 Attachment enhanced 293 cells
PCT/US1996/008081 WO1996038725A1 (en) 1995-05-30 1996-05-30 Attachment enhanced 293 cells

Publications (2)

Publication Number Publication Date
DE69633739D1 true DE69633739D1 (de) 2004-12-02
DE69633739T2 DE69633739T2 (de) 2005-12-01

Family

ID=23799277

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69633739T Expired - Lifetime DE69633739T2 (de) 1995-05-30 1996-05-30 293-zellen mit erhöhter anhaftung.

Country Status (8)

Country Link
US (3) US5683903A (de)
EP (1) EP0871885B1 (de)
JP (1) JPH11506911A (de)
AU (1) AU6377696A (de)
CA (1) CA2222718C (de)
DE (1) DE69633739T2 (de)
WO (1) WO1996038725A1 (de)
ZA (1) ZA964368B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP438598A0 (en) 1998-06-29 1998-07-23 Garvan Institute Of Medical Research NPY-Y7 receptor gene
ES2272296T3 (es) * 1999-06-18 2007-05-01 Research Foundation Of State University Of New York Grupos de borrelia burgdorferi que producen la enfermedad de lyme en humanos.
DE10132255A1 (de) * 2001-07-04 2003-01-23 Achter Viktor Gmbh & Co Kg Kunstwildleder und ein Herstellungsverfahren hierfür
US7217566B2 (en) * 2003-03-24 2007-05-15 Invitrogen Corporation Attached cell lines
EP2311994A1 (de) 2003-08-01 2011-04-20 Life Technologies Corporation Zusammensetzungen und Verfahren zur Aufreinigung kurzer RNA-Moleküle und anderer Nukleinsäuren

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340977C (en) * 1988-11-15 2000-04-25 Monty Krieger Scavenger receptor protein and antibody thereto
JPH03290184A (ja) * 1990-04-06 1991-12-19 Chugai Pharmaceut Co Ltd スカベンジャーレセプター産生動物細胞
EP0572541A1 (de) * 1991-02-22 1993-12-08 Massachusetts Institute Of Technology Behandlung des endotoxinschocks
AU5457294A (en) * 1992-10-29 1994-05-24 Board Of Regents, The University Of Texas System Adenovirus-mediated ldl receptor gene transfer and targeting

Also Published As

Publication number Publication date
EP0871885B1 (de) 2004-10-27
AU6377696A (en) 1996-12-18
DE69633739T2 (de) 2005-12-01
US5683903A (en) 1997-11-04
US5863798A (en) 1999-01-26
EP0871885A1 (de) 1998-10-21
CA2222718C (en) 2005-07-12
WO1996038725A1 (en) 1996-12-05
ZA964368B (en) 1996-12-09
JPH11506911A (ja) 1999-06-22
US5919636A (en) 1999-07-06
EP0871885A4 (de) 2000-11-22
CA2222718A1 (en) 1996-12-05

Similar Documents

Publication Publication Date Title
DE69632238D1 (de) Katheter mit plattenförmiger Elektrodenanordnung
DE69600968D1 (de) Organopolysiloxanzusammensetzung mit verbesserter Adhäsion
DE69636353D1 (de) Datenübetragungsvorrichtung.
NL1004863A1 (nl) 5-Amino-4-ethylsulfinyl-1-arylpyrazolen.
TR199600849A2 (tr) 1alfa-26 dihidroksi -D-homo-vitamin D3.
DE59610826D1 (de) Doppelpumpe mit ladepumpe
NO960223D0 (no) 2,9-disubstituerte purin-6-oner
BR9609884A (pt) N-aril- 1,2,4-triazolin-5-onas
DE69618634D1 (de) 1,4-benzodioxin-derivate
NL1000095C2 (nl) Rolhor.
DE69714358D1 (de) 9,10-disubstituierte campothecinderivate mit antitumoraktivität
FI98105B (fi) Mikroliuska-aaltoputkisiirtymä
DE69633739D1 (de) 293-zellen mit erhöhter anhaftung.
TR199600656A2 (tr) Piperidinilmetiloksazolidinonlar.
DE69604385D1 (de) Isocumarine mit antitumorwirkung
DE69621809D1 (de) Mit metallocen stabilisiertes alumoxan
DE69206024D1 (de) Beschichtungsküvette.
FI954919A (fi) Helikopteri-lentokone
ITRM930261A0 (it) La batteria intelligente.
BR9610047A (pt) 1,3,4-oxadiazolin-2-onas
ITIS950001A0 (it) La tartaruga
FIU950505U0 (fi) Kardat stickat roer
ITLI950008V0 (it) La calessuna
ES1032458Y (es) Estrctura porta-bidones.
NL194303B (nl) Verbindingsconstructie.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: SMITHKLINE BEECHAM CORPORATION, PHILADELPHIA, PA.,

8328 Change in the person/name/address of the agent

Representative=s name: VOSSIUS & PARTNER, 81675 MUENCHEN

8364 No opposition during term of opposition